Asadi-Lari M - Search Results

1

Cytoplasmic expression of DCLK1-S, a novel DCLK1 isoform, is associated with tumor aggressiveness and worse disease-specific survival in colorectal cancer.

Kalantari E, Ghods R, Saeednejad Zanjani L, Rahimi M, Eini L, Razmi M, Asadi-Lari M, Madjd Z. Kalantari E, et al. Cancer Biomark. 2022;33(3):277-289. doi: 10.3233/CBM-210330. Cancer Biomark. 2022. PMID: 34958000

2

CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours.

Madjd Z, Mehrjerdi AZ, Sharifi AM, Molanaei S, Shahzadi SZ, Asadi-Lari M. Madjd Z, et al. Cancer Immun. 2009 Apr 23;9:4. Cancer Immun. 2009. PMID: 19385591 Free PMC article.

3

High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas.

Madjd Z, Ramezani B, Molanae S, Asadi-Lari M. Madjd Z, et al. Asian Pac J Cancer Prev. 2012;13(6):2973-8. doi: 10.7314/apjcp.2012.13.6.2973. Asian Pac J Cancer Prev. 2012. PMID: 22938492 Free article.

4

Do Clinical and Demographic Features of Patients with Upper-Gastrointestinal Cancer Affect their Health-related Quality of Life?

Esmaili-Hesari RA, Homai-Shandiz F, Motevallian A, Madjd Z, Solaymani-Dodaran M, Asadi-Lari M. Esmaili-Hesari RA, et al. Int J Prev Med. 2012 Nov;3(11):783-90. Int J Prev Med. 2012. PMID: 23189230 Free PMC article.

5

BRCA1 Protein Expression Level and CD44(+)Phenotype in Breast Cancer Patients.

Madjd Z, Karimi A, Molanae S, Asadi-Lari M. Madjd Z, et al. Cell J. 2011 Fall;13(3):155-62. Epub 2011 Sep 23. Cell J. 2011. PMID: 23508738 Free PMC article.

6

Application of stem cells in targeted therapy of breast cancer: a systematic review.

Madjd Z, Gheytanchi E, Erfani E, Asadi-Lari M. Madjd Z, et al. Asian Pac J Cancer Prev. 2013;14(5):2789-800. doi: 10.7314/apjcp.2013.14.5.2789. Asian Pac J Cancer Prev. 2013. PMID: 23803033 Free article. Review.

7

Expression of CD133 cancer stem cell marker in melanoma: a systematic review and meta-analysis.

Madjd Z, Erfani E, Gheytanchi E, Moradi-Lakeh M, Shariftabrizi A, Asadi-Lari M. Madjd Z, et al. Int J Biol Markers. 2016 May 28;31(2):e118-25. doi: 10.5301/jbm.5000209. Int J Biol Markers. 2016. PMID: 27102864 Free article. Review.

8

Prediction of the treatment response in ovarian cancer: a ctDNA approach.

Sharbatoghli M, Vafaei S, Aboulkheyr Es H, Asadi-Lari M, Totonchi M, Madjd Z. Sharbatoghli M, et al. J Ovarian Res. 2020 Oct 19;13(1):124. doi: 10.1186/s13048-020-00729-1. J Ovarian Res. 2020. PMID: 33076944 Free PMC article. Review.

9

Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis.

Kalantari E, Razmi M, Tajik F, Asadi-Lari M, Ghods R, Madjd Z. Kalantari E, et al. Cancer Cell Int. 2022 Jun 18;22(1):217. doi: 10.1186/s12935-022-02632-9. Cancer Cell Int. 2022. PMID: 35717205 Free PMC article. Review.

10

Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients.

Sharbatoghli M, Fattahi F, Aboulkheyr Es H, Akbari A, Akhavan S, Ebrahimi M, Asadi-Lari M, Totonchi M, Madjd Z. Sharbatoghli M, et al. Front Genet. 2022 Jul 22;13:938985. doi: 10.3389/fgene.2022.938985. eCollection 2022. Front Genet. 2022. PMID: 35938032 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters